trending Market Intelligence /marketintelligence/en/news-insights/trending/liVXtLzR6jSL0HFvSKW4Vw2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Constellation seeks to raise $224.3M via common stock offering

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Constellation seeks to raise $224.3M via common stock offering

Constellation Pharmaceuticals Inc. seeks to raise about $224.3 million in gross proceeds from a public offering of its common stock.

The Cambridge, Mass.-based biotech company, which develops treatments for cancers with abnormal gene expression and drug resistance, is offering 6.5 million shares for $34.5 each.

Underwriters have also been given a 30-day option to buy up to an additional 975,000 common shares from the company, Constellation said in a Dec. 10 press release.

The offering is expected to close Dec. 13, the company added.

J.P. Morgan, Jefferies and Cowen are the joint book-running managers; RBC Capital Markets is the book runner; and SunTrust Robinson Humphrey is the lead manager for the offering.